Baidu
map

2019 EULAR建议:干燥综合征的局部和全身治疗

2019-10-31 欧洲抗风湿病联盟 Ann Rheum Dis. 2019 Oct 31.

2019年10月,欧洲抗风湿病联盟(EULAR)发布了干燥综合征的局部和全身治疗建议,近几十年来对于干燥综合征的治疗管理并没有发生实质性的改变,其治疗决策的制定在临床实践中仍然充满挑战。本文主要针对干燥综合征的局部和全身治疗提供管理建议。

中文标题:

2019 EULAR建议:干燥综合征的局部和全身治疗

英文标题:

EULAR recommendations for the management of Sjögren''s syndrome with topical and systemic therapies.

发布机构:

欧洲抗风湿病联盟

发布日期:

2019-10-31

简要介绍:

2019年10月,欧洲抗风湿病联盟(EULAR)发布了干燥综合征的局部和全身治疗建议,近几十年来对于干燥综合征的治疗管理并没有发生实质性的改变,其治疗决策的制定在临床实践中仍然充满挑战。本文主要针对干燥综合征的局部和全身治疗提供管理建议。

 

拓展指南:干燥综合征相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 EULAR建议:干燥综合征的局部和全身治疗)] GetToolGuiderByIdResponse(projectId=1, id=3ed8f1c001823e25, title=2019 EULAR建议:干燥综合征的局部和全身治疗, enTitle=EULAR recommendations for the management of Sjögren''s syndrome with topical and systemic therapies., guiderFrom=Ann Rheum Dis. 2019 Oct 31., authorId=null, author=, summary=2019年10月,欧洲抗风湿病联盟(EULAR)发布了干燥综合征的局部和全身治疗建议,近几十年来对于干燥综合征的治疗管理并没有发生实质性的改变,其治疗决策的制定在临床实践中仍然充满挑战。本文主要针对干燥综合征的局部和全身治疗提供管理建议。 , cover=, journalId=null, articlesId=null, associationId=258, associationName=欧洲抗风湿病联盟, associationIntro=null, copyright=0, guiderPublishedTime=Thu Oct 31 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年10月,欧洲抗风湿病联盟(EULAR)发布了干燥综合征的局部和全身治疗建议,近几十年来对于干燥综合征的治疗管理并没有发生实质性的改变,其治疗决策的制定在临床实践中仍然充满挑战。本文主要针对干燥综合征的局部和全身治疗提供管理建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>干燥综合征</font>相关指南:</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=ceef51c001e17652" title="原发性干燥综合征多学科诊治建议" target=_blank>原发性干燥综合征多学科诊治建议</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=f39b01c001323068" title="2016 ACR/ELAR共识:原发性干燥综合征的分类标准" target=_blank>2016 ACR/ELAR共识:原发性干燥综合征的分类标准</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=3bc441c001239ec5" title="2016 SSF指南:干燥综合征风湿性疾病表现的治疗-生物制剂的使用,疲劳以及炎性肌肉骨骼疼痛的管理" target=_blank>2016 SSF指南:干燥综合征风湿性疾病表现的治疗-生物制剂的使用,疲劳以及炎性肌肉骨骼疼痛的管理</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=215f61c000e9617f" title="2010 干燥综合征诊断及治疗指南" target=_blank>2010 干燥综合征诊断及治疗指南</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=136df1c000e598e1" title="2011EULAR 干燥综合征活动性标志物研究新进展" target=_blank>2011EULAR 干燥综合征活动性标志物研究新进展</a></li> 更多信息请点击:<a href="//www.sandwebs.com/guideline/list.do?q=%E5%B9%B2%E7%87%A5%E7%BB%BC%E5%90%88%E5%BE%81" target=_blank>有关干燥综合征更多指南</a></ul>, tagList=[TagDto(tagId=9597, tagName=干燥综合征)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10002, appHits=441, showAppHits=8, pcHits=4642, showPcHits=6874, likes=79, shares=15, comments=6, approvalStatus=1, publishedTime=Mon Nov 04 22:46:54 CST 2019, publishedTimeString=2019-10-31, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Nov 04 22:46:54 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:34:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 EULAR建议:干燥综合征的局部和全身治疗)])
2019 EULAR建议:干燥综合征的局部和全身治疗
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2093909, encodeId=7f6d209390937, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b15706800, createdName=ms3000000964032118, createdTime=Sat Oct 15 11:38:29 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926568, encodeId=a20c92656869, content=学习下,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37185462345, createdName=knyd888, createdTime=Tue Feb 23 12:05:36 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906327, encodeId=234990632e6d, content=前来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=195c5206565, createdName=1474e8d5m68暂无昵称, createdTime=Wed Dec 09 11:12:39 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900800, encodeId=ac40900800b7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Fri Nov 20 15:01:25 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374806, encodeId=4fe33e4806d6, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Nov 04 23:22:11 CST 2019, time=2019-11-04, status=1, ipAttribution=)]
    2022-10-15 ms3000000964032118

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2093909, encodeId=7f6d209390937, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b15706800, createdName=ms3000000964032118, createdTime=Sat Oct 15 11:38:29 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926568, encodeId=a20c92656869, content=学习下,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37185462345, createdName=knyd888, createdTime=Tue Feb 23 12:05:36 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906327, encodeId=234990632e6d, content=前来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=195c5206565, createdName=1474e8d5m68暂无昵称, createdTime=Wed Dec 09 11:12:39 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900800, encodeId=ac40900800b7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Fri Nov 20 15:01:25 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374806, encodeId=4fe33e4806d6, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Nov 04 23:22:11 CST 2019, time=2019-11-04, status=1, ipAttribution=)]
    2021-02-23 knyd888

    学习下,

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2093909, encodeId=7f6d209390937, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b15706800, createdName=ms3000000964032118, createdTime=Sat Oct 15 11:38:29 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926568, encodeId=a20c92656869, content=学习下,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37185462345, createdName=knyd888, createdTime=Tue Feb 23 12:05:36 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906327, encodeId=234990632e6d, content=前来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=195c5206565, createdName=1474e8d5m68暂无昵称, createdTime=Wed Dec 09 11:12:39 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900800, encodeId=ac40900800b7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Fri Nov 20 15:01:25 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374806, encodeId=4fe33e4806d6, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Nov 04 23:22:11 CST 2019, time=2019-11-04, status=1, ipAttribution=)]
    2020-12-09 1474e8d5m68暂无昵称

    前来学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2093909, encodeId=7f6d209390937, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b15706800, createdName=ms3000000964032118, createdTime=Sat Oct 15 11:38:29 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926568, encodeId=a20c92656869, content=学习下,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37185462345, createdName=knyd888, createdTime=Tue Feb 23 12:05:36 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906327, encodeId=234990632e6d, content=前来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=195c5206565, createdName=1474e8d5m68暂无昵称, createdTime=Wed Dec 09 11:12:39 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900800, encodeId=ac40900800b7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Fri Nov 20 15:01:25 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374806, encodeId=4fe33e4806d6, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Nov 04 23:22:11 CST 2019, time=2019-11-04, status=1, ipAttribution=)]
    2020-11-20 lexi Liao

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2093909, encodeId=7f6d209390937, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b15706800, createdName=ms3000000964032118, createdTime=Sat Oct 15 11:38:29 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926568, encodeId=a20c92656869, content=学习下,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37185462345, createdName=knyd888, createdTime=Tue Feb 23 12:05:36 CST 2021, time=2021-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906327, encodeId=234990632e6d, content=前来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=195c5206565, createdName=1474e8d5m68暂无昵称, createdTime=Wed Dec 09 11:12:39 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900800, encodeId=ac40900800b7, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Fri Nov 20 15:01:25 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374806, encodeId=4fe33e4806d6, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Nov 04 23:22:11 CST 2019, time=2019-11-04, status=1, ipAttribution=)]
    2019-11-04 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

Baidu
map
Baidu
map
Baidu
map